Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic's new Ev3 unit pays $1.3m in whistleblower suit; GPOs: Premier buys the rest of direct sourcer S2S Global; CareFusion crushes it in final quarter; BD beats Q1 estimates, raises outlook, shares jump; Zimmer revises Biomet bid for EU regulators
A labeling miscue prompts Covidien to recall 2 models of its Trellis clot-busting infusion device.
UPDATED Feb. 12, 2015, with new information from Medtronic.
Results from a study of Medtronic's ClosureFast varicose vein device, published this month in the British Journal of Surgery, show an 91.9% occlusion rate after 5 years.
Here's a look at some of the top regulatory stories for medical device companies this week: Regulators deal Wright Medical a double whammy; Medtronic wins FDA approval for Melody pulmonary valve; FDA approves Cohera's TissuGlu surgical sealant; FDA approves Medtronic's Pipeline Flex aneurysm device; Sorin wins MRI-safe pacemaker approval in Japan
Medtronic agrees to settle for $1.25 million a whistleblower lawsuit inherited from the Ev3 subsidiary it acquired in the $50 billion Covidien deal.
The FDA grants pre-market approval for the Pipeline Flex device for treating brain aneurysms Medtronic acquired along with Covidien.
St. Jude Medical CEO Daniel Starks tells analysts that the medical device company doesn't need to follow it's competitors down the path of consolidation.